About
Technology
Issues
FAQ
Links
Official Page
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.